Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Meeting Intimation for Results & Closure of Trading Window

 Zydus Wellness Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on August 02, 2016, inter alia, to consider & approve the unaudited financial results for the quarter ended on June 30, 2016.Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will remain closed from July 24, 2016 to...
11-07-2016
Bigul

Zydus gets FDA nod for diabetes drug

 The company today informed in a statement that it has received the nod from the US drug regulator to market the drug in strengths of 60 mg and 120 mg
11-07-2016
Bigul

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016

 Zydus Wellness Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
07-07-2016
Bigul

Cut-off Date

 Zydus Wellness Ltd has informed BSE that pursuant to Companies [Management and Administration] Amendment Rules, 2015, the Company has fixed July 27, 2016 as the Cut-Off Date for determining the eligibility of the members entitled to vote by electronic means and at the venue of Twenty Second Annual General Meeting scheduled to be held on August 03, 2016 at 10:00 a.m....
06-07-2016
Bigul

Shareholding for the Period Ended June 30, 2016

 Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here
06-07-2016
Bigul

Zydus Wellness steps on gas: plans Everyuth re-launch, eyes buy-outs

 Firm is setting up new plant in Sikkim for Rs 35 crore; expected to go onstream within FY17
27-06-2016
Bigul

Zydus group inks pact with Eczacibasi to market biotech products

 The collaboration agreement involves the import of bio-similars that are currently unavailable in Turkey, especially for the treatment of cancer.
15-06-2016
Bigul

Investor Presentation

 Zydus Wellness Ltd has submitted to BSE a copy of Investor Presentation
13-06-2016
Bigul

Zydus gets USFDA nod for phase II clinical trial of Saroglitazar

 The company will be allowed to evaluate Saroglitazar in strengths of 1mg, 2mg and 4mg versus placebo
04-06-2016
Bigul

Zydus gets final USFDA nod to sell Voriconazole Tab

 Estimates sale of US$ 92.8-mn for the tablet, used to treat fungal infections
25-05-2016
Next Page
Close

Let's Open Free Demat Account